{"id":386,"date":"2013-03-01T23:58:48","date_gmt":"2013-03-02T07:58:48","guid":{"rendered":"https:\/\/drugpolicy.ca\/?p=386"},"modified":"2021-11-30T08:49:30","modified_gmt":"2021-11-30T16:49:30","slug":"is-this-the-future-of-drug-law","status":"publish","type":"post","link":"https:\/\/new.drugpolicy.ca\/fr\/is-this-the-future-of-drug-law\/","title":{"rendered":"Is This The Future of Drug Law?"},"content":{"rendered":"

This week the New Zealand government will publish its Psychoactive Drugs Bill<\/a>. Under the new regulations proposed in the bill<\/a>, \u201clegal highs\u201d would have to undergo an approval process before being brought to market. The New Zealand Ministry of Health would then issue licenses relating to the importation, manufacture, and sale of psychoactive substances covered by the bill. This process would place the burden on the synthetic drug industry, which would have to prove its products are safe before being made available to the consumer.<\/p>\n

From the BBC<\/a>:<\/p>\n

\u201cThe new law is a response to the problem of \u201clegal highs\u201d, but is being seized upon by reformers because it crosses a Rubicon \u2013 designing a legislative framework built upon regulation rather than prohibition.\u201d<\/p>\n

Therein lies the significance of this bill \u2013 it is a response to a drug-related issue that uses regulation rather than prohibition as the method of control. Instead of simply issuing criminal bans on emerging drugs, a method that has proven a failure time and time again, New Zealand is choosing to shift the focus to protecting public health.<\/p>\n

Rather than allowing these substances to be controlled by the criminal element, they will instead exist within a regulated market. Beyond health considerations, a variety of restrictions will apply to the drugs, such as hefty fines and jail time for any manufacturer caught selling their products to minors.<\/p>\n

This bill presents a timely and thoughtful solution to a rapidly emerging problem. In 2012, the European Monitoring Centre for Drugs and Drugs Addiction reported<\/a> that a new \u201clegal high\u201d goes on sale every week.<\/p>\n

Thus far, The Canadian government\u2019s response to the phenomenon of \u201clegal highs\u201d has been a traditional approach of banning a substance when the media brings it to the public\u2019s attention, as was the case with the great MDPV (aka Bath Salts) scare of 2012.<\/p>\n

Last September, after the federal government proposed that MDPV be included in Schedule I of the Controlled Drugs and Substances act, we issued a submission<\/a> to Health Canada recommending that banning the substance would have unintended negative effects and that the government should regulate, rather than criminalize its use.<\/p>\n

The CDPC is optimistic about New Zealand\u2019s Psychoactive Drug Bill as it is line with a greater paradigm shift occurring in many countries around the world. Leaving the control of drugs and drug quality in the hands of criminals protects no one and creates a litany of disastrous side effects. We look forward to seeing the bill implemented in the near future.<\/p>\n

If you would like to learn more about how we are building a better drug policy for Canada, please sign up to our mailing list<\/a> and we will keep you up to date on news and upcoming campaigns.<\/p>\n","protected":false},"excerpt":{"rendered":"

This week the New Zealand government will publish its Psychoactive Drugs Bill. Under the new regulations proposed in the bill, \u201clegal highs\u201d would have to undergo an approval process before being brought to market. The New Zealand Ministry of Health would then issue licenses relating to the importation, manufacture, and sale of psychoactive substances covered […]<\/p>\n","protected":false},"author":1,"featured_media":3104,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_crdt_document":"","footnotes":""},"categories":[1,20],"tags":[],"class_list":["post-386","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-all","category-drug-law-reform"],"acf":[],"mb":[],"yoast_head":"\nIs This The Future of Drug Law? - Canadian Drug Policy Coalition<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/new.drugpolicy.ca\/fr\/is-this-the-future-of-drug-law\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Is This The Future of Drug Law? - Canadian Drug Policy Coalition\" \/>\n<meta property=\"og:description\" content=\"This week the New Zealand government will publish its Psychoactive Drugs Bill. Under the new regulations proposed in the bill, \u201clegal highs\u201d would have to undergo an approval process before being brought to market. The New Zealand Ministry of Health would then issue licenses relating to the importation, manufacture, and sale of psychoactive substances covered […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/new.drugpolicy.ca\/fr\/is-this-the-future-of-drug-law\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Drug Policy Coalition\" \/>\n<meta property=\"article:published_time\" content=\"2013-03-02T07:58:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-30T16:49:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.canadiandrugpolicy.ca\/wp-content\/uploads\/2013\/04\/CDPC_LegalHighs_Blog_415x415px-S.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"415\" \/>\n\t<meta property=\"og:image:height\" content=\"415\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/is-this-the-future-of-drug-law\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/is-this-the-future-of-drug-law\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/dfa227f7f7fb3d70383391c4c01ec657\"},\"headline\":\"Is This The Future of Drug Law?\",\"datePublished\":\"2013-03-02T07:58:48+00:00\",\"dateModified\":\"2021-11-30T16:49:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/is-this-the-future-of-drug-law\\\/\"},\"wordCount\":464,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/is-this-the-future-of-drug-law\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/new.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2013\\\/04\\\/CDPC_LegalHighs_Blog_415x415px-S.jpg\",\"articleSection\":[\"All\",\"Drug Law Reform\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/is-this-the-future-of-drug-law\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/is-this-the-future-of-drug-law\\\/\",\"url\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/is-this-the-future-of-drug-law\\\/\",\"name\":\"Is This The Future of Drug Law? - Canadian Drug Policy Coalition\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/is-this-the-future-of-drug-law\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/is-this-the-future-of-drug-law\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/new.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2013\\\/04\\\/CDPC_LegalHighs_Blog_415x415px-S.jpg\",\"datePublished\":\"2013-03-02T07:58:48+00:00\",\"dateModified\":\"2021-11-30T16:49:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/is-this-the-future-of-drug-law\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/is-this-the-future-of-drug-law\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/is-this-the-future-of-drug-law\\\/#primaryimage\",\"url\":\"https:\\\/\\\/new.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2013\\\/04\\\/CDPC_LegalHighs_Blog_415x415px-S.jpg\",\"contentUrl\":\"https:\\\/\\\/new.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2013\\\/04\\\/CDPC_LegalHighs_Blog_415x415px-S.jpg\",\"width\":415,\"height\":415},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/is-this-the-future-of-drug-law\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Is This The Future of Drug Law?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"name\":\"Canadian Drug Policy Coalition\",\"description\":\"Change policy. Save lives.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\",\"name\":\"Canadian Drug Policy Coalition\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"contentUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"width\":332,\"height\":333,\"caption\":\"Canadian Drug Policy Coalition\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/dfa227f7f7fb3d70383391c4c01ec657\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\\\/\\\/new.drugpolicy.ca\\\/fr\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Is This The Future of Drug Law? - Canadian Drug Policy Coalition","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/new.drugpolicy.ca\/fr\/is-this-the-future-of-drug-law\/","og_locale":"fr_FR","og_type":"article","og_title":"Is This The Future of Drug Law? - Canadian Drug Policy Coalition","og_description":"This week the New Zealand government will publish its Psychoactive Drugs Bill. Under the new regulations proposed in the bill, \u201clegal highs\u201d would have to undergo an approval process before being brought to market. The New Zealand Ministry of Health would then issue licenses relating to the importation, manufacture, and sale of psychoactive substances covered […]","og_url":"https:\/\/new.drugpolicy.ca\/fr\/is-this-the-future-of-drug-law\/","og_site_name":"Canadian Drug Policy Coalition","article_published_time":"2013-03-02T07:58:48+00:00","article_modified_time":"2021-11-30T16:49:30+00:00","og_image":[{"width":415,"height":415,"url":"https:\/\/www.canadiandrugpolicy.ca\/wp-content\/uploads\/2013\/04\/CDPC_LegalHighs_Blog_415x415px-S.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"admin","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/new.drugpolicy.ca\/fr\/is-this-the-future-of-drug-law\/#article","isPartOf":{"@id":"https:\/\/new.drugpolicy.ca\/fr\/is-this-the-future-of-drug-law\/"},"author":{"name":"admin","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/person\/dfa227f7f7fb3d70383391c4c01ec657"},"headline":"Is This The Future of Drug Law?","datePublished":"2013-03-02T07:58:48+00:00","dateModified":"2021-11-30T16:49:30+00:00","mainEntityOfPage":{"@id":"https:\/\/new.drugpolicy.ca\/fr\/is-this-the-future-of-drug-law\/"},"wordCount":464,"commentCount":0,"publisher":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization"},"image":{"@id":"https:\/\/new.drugpolicy.ca\/fr\/is-this-the-future-of-drug-law\/#primaryimage"},"thumbnailUrl":"https:\/\/new.drugpolicy.ca\/wp-content\/uploads\/2013\/04\/CDPC_LegalHighs_Blog_415x415px-S.jpg","articleSection":["All","Drug Law Reform"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/new.drugpolicy.ca\/fr\/is-this-the-future-of-drug-law\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/new.drugpolicy.ca\/fr\/is-this-the-future-of-drug-law\/","url":"https:\/\/new.drugpolicy.ca\/fr\/is-this-the-future-of-drug-law\/","name":"Is This The Future of Drug Law? - Canadian Drug Policy Coalition","isPartOf":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/new.drugpolicy.ca\/fr\/is-this-the-future-of-drug-law\/#primaryimage"},"image":{"@id":"https:\/\/new.drugpolicy.ca\/fr\/is-this-the-future-of-drug-law\/#primaryimage"},"thumbnailUrl":"https:\/\/new.drugpolicy.ca\/wp-content\/uploads\/2013\/04\/CDPC_LegalHighs_Blog_415x415px-S.jpg","datePublished":"2013-03-02T07:58:48+00:00","dateModified":"2021-11-30T16:49:30+00:00","breadcrumb":{"@id":"https:\/\/new.drugpolicy.ca\/fr\/is-this-the-future-of-drug-law\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/new.drugpolicy.ca\/fr\/is-this-the-future-of-drug-law\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/new.drugpolicy.ca\/fr\/is-this-the-future-of-drug-law\/#primaryimage","url":"https:\/\/new.drugpolicy.ca\/wp-content\/uploads\/2013\/04\/CDPC_LegalHighs_Blog_415x415px-S.jpg","contentUrl":"https:\/\/new.drugpolicy.ca\/wp-content\/uploads\/2013\/04\/CDPC_LegalHighs_Blog_415x415px-S.jpg","width":415,"height":415},{"@type":"BreadcrumbList","@id":"https:\/\/new.drugpolicy.ca\/fr\/is-this-the-future-of-drug-law\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.drugpolicy.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Is This The Future of Drug Law?"}]},{"@type":"WebSite","@id":"https:\/\/www.drugpolicy.ca\/fr\/#website","url":"https:\/\/www.drugpolicy.ca\/fr\/","name":"Canadian Drug Policy Coalition","description":"Change policy. Save lives.","publisher":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.drugpolicy.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization","name":"Canadian Drug Policy Coalition","url":"https:\/\/www.drugpolicy.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","contentUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","width":332,"height":333,"caption":"Canadian Drug Policy Coalition"},"image":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/person\/dfa227f7f7fb3d70383391c4c01ec657","name":"admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/new.drugpolicy.ca\/fr\/author\/admin\/"}]}},"mfb_rest_fields":["title","yoast_head","yoast_head_json"],"_links":{"self":[{"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/386","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/comments?post=386"}],"version-history":[{"count":1,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/386\/revisions"}],"predecessor-version":[{"id":17254,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/386\/revisions\/17254"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media\/3104"}],"wp:attachment":[{"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media?parent=386"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/categories?post=386"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/new.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/tags?post=386"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}